SpaceX IPO Set to Be a Catalyst for 2026 IPO Boom: ETFs to Gain

SpaceX could be the catalyst for a surge as the U.S. IPO market eyes a comeback. ETFs like FPX, IPO and IPOS offer an easy way to gain exposure.

Zacks Investment Research • Apr 2, 2026

U.S. IPO Proceeds Set to Quadruple in 2026? ETFs to Consider

As dealmaking momentum builds, the U.S. IPO market may be gearing up for a comeback in 2026. ETFs like FPX, IPO, FPXI and IPOS provide a low-stress way to play the trend.

Zacks Investment Research • Feb 10, 2026

Exciting IPO Lineup Ahead? Join the Action With These ETFs

With blockbuster IPOs lining up, ETFs provide a low-stress way to play the trend.

Zacks Investment Research • Jan 26, 2026

Positive Momentum Continues to Build for IPO ETFs

Figma, Circle, and CoreWeave are just a few names to remind investors that the initial public offering (IPO) market is alive and kicking despite the market challenges in 2025. This opens the door into a room with IPO-focused exchange-traded funds (ETFs) that can provide niche exposure to these up and comers.

ETF Trends • Sep 24, 2025

ETFs to Play IPO Market's Rebound in 2025

IPO market momentum accelerates as U.S. listings surge, boosting ETFs like FPX, IPO, FPXI and IPOS across the board.

Zacks Investment Research • Jul 3, 2025

A Bullish 2025 for the IPO Market? ETFs to Consider

Expectations of a favorable business climate and less stringent regulations under the incoming Trump administration have made investors optimistic about the future of the IPO market. Look at ETFs to capitalize on the optimism.

Zacks Investment Research • Jan 22, 2025

Global Risk-On Sentiments to Strengthen in 2H24? ETFs to Gain

The International Monetary Fund (IMF) forecasts global central banks to start interest rate cuts in the latter half of the year.

Zacks Investment Research • Apr 17, 2024

Alibaba's Q4 Earnings Put These ETFs in Focus

Alibaba beat earnings estimates but missed on revenues when it reported fourth-quarter fiscal 2023 results.

Zacks Investment Research • May 19, 2023

As Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses Estimates

Growth stock Stevanato plunged after first quarter earnings as sales from Covid related services fell; maintained its full year outlook The post As Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses Estimates appeared first on Investor's Business Daily.

Investors Business Daily • May 4, 2023

Is The SPAC Party Over?

The SPAC market has somewhat reset from the initial euphoria. SPACs will continue to provide a useful and efficient avenue to take private companies public.

Seeking Alpha • Aug 12, 2021